store at low temperature
store at -80°C
Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 51,000 |
5 mg | 在庫あり | ¥ 106,500 |
10 mg | 在庫あり | ¥ 201,500 |
25 mg | 在庫あり | ¥ 294,000 |
50 mg | 在庫あり | ¥ 404,000 |
説明 | Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells. |
In vitro | Mupadolimab induces increased expression of markers associated with B cell maturation and antigen presentation, transformation into plasma cells, as well as increased secretion of IgM and IgG[1]. |
In vivo | Mupadolimab (10 mg/kg; intraperitoneal injection; once daily for 15 days) stimulates antigen-specific humoral immunity in NSG-SGM3 mice infected with SARS-CoV-2[1]. |
別名 | CPI-006 |
分子量 | N/A |
CAS No. | 2451856-97-4 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mupadolimab 2451856-97-4 Immunology/Inflammation CD73 CPI006 CPI-006 CPI 006 Inhibitor inhibitor inhibit